期刊文献+

孕中期高危孕妇外周血中胎儿游离DNA与高危产前诊断指征相关性分析 被引量:3

Correlation analysis of cell-free fetal DNA in peripheral blood of high-risk pregnant women in the second trimester and high-risk indications of prenatal diagnosis
下载PDF
导出
摘要 目的分析孕中期高危孕妇外周血中胎儿游离DNA(Cell-free fetal DNA,cffDNA)与高危产前诊断指征相关性。方法研究对象为2018年7月-2019年7月在遂宁市中心医院产前诊断中心接受外周血cffDNA筛查的3176例孕中期高危孕妇,记录高危产前诊断指征、cffDNA检测结果,分析不同高危产前诊断指征的孕中期高危孕妇外周血cffDNA筛查结果,以染色体核型检查结果为对照,分析孕中期高危孕妇外周血中cffDNA的筛查价值。结果3176例孕中期高危孕妇的产前诊断指征分别为高龄(年龄≥35岁)33.63%(1068/3176)、血清学筛查临界风险31.30%(994/3176)、血清学筛查高风险18.29%(581/3176)、不良孕产史2.90%(92/3176)、B超软指标异常2.39%(76/3176)、B超提示胎儿结构异常0.22%(7/3176)、其他11.30%(359/3176)。cffDNA检查结果显示57(1.79%)例孕妇外周血cffDNA检查结果为高风险,以B超提示胎儿结构异常的孕妇外周血cffDNA检测高风险相对比例最高,为28.57%,血清学筛查高风险(2.75%)、不良孕产史(2.17%)、高龄(1.97%)、血清学筛查临界风险(1.21%)、其他(1.12%)。57例孕妇外周血cffDNA高风险患者中,56.14%的孕妇染色体核型分析染色体核型异常,cffDNA高风险预测21三体的准确率最高(82.60%)。结论孕中期高危孕妇外周血中cffDNA与高危产前诊断指征存在一定关系,孕中期开展外周血cffDNA筛查期较高的灵敏度、特异度,具有无创、准确率高的特点,尤其是对T21的筛查具有较高的准确度。 Objective To analyze the correlation between cell-free fetal DNA(cffDNA)in peripheral blood of highrisk pregnant women in the second trimester and high-risk indications of prenatal diagnosis.Methods A total of 3,176 high-risk pregnant women in the second trimester who underwent peripheral blood cffDNA screening at prenatal diagnosis center of the hospital during the period from July 2018 to July 2019 were selected as the research subjects.The high-risk indications of prenatal diagnosis and cffDNA test results were recorded.Peripheral blood cffDNA screening results of subjects with different indications of prenatal high-risk diagnosis were analyzed.The examination results of chromosome karyotypes were taken as control to analyze the value of peripheral blood cffDNA screening among highrisk pregnant women in the second trimester.Results The indications of prenatal diagnosis in this study included advanced age(≥35 years old)[33.63%(1,068/3,176)],critical risk of serological screening[31.30%(994/3,175)],high risk of serological screening[18.29%(581/3,176)],history of adverse pregnancy and delivery[2.90%(92/3,176)],abnormal soft indexes of B-ultrasound[2.39%(76/3,176)],abnormal fetal structure displayed by B-ultrasound[0.22%(7/3,176)]and other factors[11.30%(359/3,176)].The cffDNA test results of 57(1.79%)cases showed high risk.The proportion of abnormal fetal structure detected by B-ultrasound was the highest(28.57%),followed by high risk of serological screening(2.75%),history of adverse pregnancy and delivery(2.17%),advanced age(1.97%),critical risk of serological screening(1.21%)and other factors(1.12%).Among 57 high-risk pregnant women with peripheral blood cffDNA,56.14%had abnormal karyotypes.The accuracy rate of high-risk cffDNA for predicting trisomy 21 was the highest,which was 82.60%.Conclusion The cffDNA in peripheral blood of high-risk pregnant women in the second trimester is related to high-risk indications of prenatal diagnosis.Maternal peripheral blood cffDNA screening in the second trimester has rel
作者 赵咏梅 张传英 席海林 ZHAO Yong-mei;ZHANG Chuan-ying;XI Hai-lin(Prenatal Diagnostic Laboratory of Sichuan Suining Central Hospital,Suining Sichuan 629000 China)
出处 《中国实验诊断学》 2021年第2期229-232,共4页 Chinese Journal of Laboratory Diagnosis
关键词 孕中期 高危孕妇 外周血 胎儿游离DNA 高危产前诊断指征 Second trimester High-risk pregnant woman Peripheral blood Cell-free fetal DNA High-risk indications of prenatal diagnosis
  • 相关文献

参考文献10

二级参考文献78

  • 1侯红瑛,李小毛,滕奔琦,尹玉竹,许成芳,易翠兴.妊娠中晚期羊水细胞核型分析[J].中国优生与遗传杂志,2006,14(8):42-44. 被引量:34
  • 2范存仁.婴幼儿智能发育测验手册.北京:团结出版社,1998:34-36. 被引量:4
  • 3中华人民共和国卫生部.中国出生缺陷防治报告(2012)[R].北京:中华人民共和国卫生部,2012,3. 被引量:30
  • 4边旭明.实用产前诊断学[M].人民卫生出版社,2011.303. 被引量:1
  • 5Mujezinovic F, Alfirevic Z. Procedure - related complicationsof amniocentesis and chorionic villous sampling . a systematicreview. Obstet Gynecol, 2007,110: 687 - 694. 被引量:1
  • 6Schuster SC. Next - generation sequencing transforms today'sbiology. Nat Methods, 2008,5: 16 - 18. 被引量:1
  • 7Dan S, Wang W,Ren J, et al. Clinical application of mas-sively parallel sequencing - based prenatal noninvasive fetaltrisomy test for trisomies 21 and 18 in 11,105 pregnancieswith mixed risk factors. Prenat Diagn, 2012, 32: 25 - 32. 被引量:1
  • 8Chiu RW, Akolekar R, Zheng YW. et al. Non - invasiveprenatal assessment of trisomy 21 by multiplexed maternalplasma DNA sequencing : large scale validity study. BMJ,2011,342: c7401. 被引量:1
  • 9Dai L,Zhu J, Liang J, et al. Birth defects surveillance inChina. World J Pediatr, 2011,7; 302- 310. 被引量:1
  • 10Canick J. Prenatal screening for trisomy 21 : recent advancesand guidelines. Clin Chem Lab Med, 2012, 50: 1003 - 1008. 被引量:1

共引文献93

同被引文献32

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部